Direct-Acting Antiviral Treatment for Hepatitis C Genotypes Uncommon in High-Income Countries: A Dutch Nationwide Cohort Study

BACKGROUND: The majority of hepatitis C virus (HCV) infections are found in low- and middle-income countries, which harbor many region-specific HCV subtypes. Nevertheless, direct-acting antiviral (DAA) trials have almost exclusively been conducted in high-income countries, where mainly epidemically...

Descripción completa

Detalles Bibliográficos
Autores principales: Isfordink, Cas J, van de Laar, Thijs J W, Rebers, Sjoerd P H, Wessels, Els, Molenkamp, Richard, Knoester, Marjolein, Baak, Bert C, van Nieuwkoop, Cees, van Hoek, Bart, Brakenhoff, Sylvia M, Blokzijl, Hans, Arends, Joop E, van der Valk, Marc, Schinkel, Janke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Major Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7881754/
https://www.ncbi.nlm.nih.gov/pubmed/33614815
http://dx.doi.org/10.1093/ofid/ofab006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7881754/
https://www.ncbi.nlm.nih.gov/pubmed/33614815
http://dx.doi.org/10.1093/ofid/ofab006

Ejemplares similares